EE438 Cost-Effectiveness of Nirsevimab Against Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV LRTD) in the US Birth Cohort
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.704
https://www.valueinhealthjournal.com/article/S1098-3015(23)03834-2/fulltext
Title :
EE438 Cost-Effectiveness of Nirsevimab Against Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV LRTD) in the US Birth Cohort
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03834-2&doi=10.1016/j.jval.2023.09.704
First page :
Section Title :
Open access? :
No
Section Order :
10190